26
|
Barcellini A, Vitolo V, Cobianchi L, Valvo F, Vischioni B, Bonora M, Fiore MR, Iannalfi A, Riva G, Ronchi S, Tornari E, Orlandi E. Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? Pancreatology 2020; 20:1004-1005. [PMID: 32418757 PMCID: PMC7217079 DOI: 10.1016/j.pan.2020.05.007] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/27/2020] [Revised: 05/07/2020] [Accepted: 05/08/2020] [Indexed: 12/11/2022]
|
27
|
Sacco S, Ballati F, Gaetani C, Lomoro P, Farina LM, Bacila A, Imparato S, Paganelli C, Buizza G, Iannalfi A, Baroni G, Valvo F, Bastianello S, Preda L. Multi-parametric qualitative and quantitative MRI assessment as predictor of histological grading in previously treated meningiomas. Neuroradiology 2020; 62:1441-1449. [PMID: 32583368 DOI: 10.1007/s00234-020-02476-y] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2020] [Accepted: 06/10/2020] [Indexed: 01/22/2023]
Abstract
PURPOSE Meningiomas are mainly benign tumors, though a considerable proportion shows aggressive behaviors histologically consistent with atypia/anaplasia. Histopathological grading is usually assessed through invasive procedures, which is not always feasible due to the inaccessibility of the lesion or to treatment contraindications. Therefore, we propose a multi-parametric MRI assessment as a predictor of meningioma histopathological grading. METHODS Seventy-three patients with 74 histologically proven and previously treated meningiomas were retrospectively enrolled (42 WHO I, 24 WHO II, 8 WHO III) and studied with MRI including T2 TSE, FLAIR, Gradient Echo, DWI, and pre- and post-contrast T1 sequences. Lesion masks were segmented on post-contrast T1 sequences and rigidly registered to ADC maps to extract quantitative parameters from conventional DWI and intravoxel incoherent motion model assessing tumor perfusion. Two expert neuroradiologists assessed morphological features of meningiomas with semi-quantitative scores. RESULTS Univariate analysis showed different distributions (p < 0.05) of quantitative diffusion parameters (Wilcoxon rank-sum test) and morphological features (Pearson's chi-square; Fisher's exact test) among meningiomas grouped in low-grade (WHO I) and higher grade forms (WHO II/III); the only exception consisted of the tumor-brain interface. A multivariate logistic regression, combining all parameters showing statistical significance in the univariate analysis, allowed discrimination between the groups of meningiomas with high sensitivity (0.968) and specificity (0.925). Heterogeneous contrast enhancement and low ADC were the best independent predictors of atypia and anaplasia. CONCLUSION Our multi-parametric MRI assessment showed high sensitivity and specificity in predicting histological grading of meningiomas. Such an assessment may be clinically useful in characterizing lesions without histological diagnosis. Key points • When surgery and biopsy are not feasible, parameters obtained from both conventional and diffusion-weighted MRI can predict atypia and anaplasia in meningiomas with high sensitivity and specificity. • Low ADC values and heterogeneous contrast enhancement are the best predictors of higher grade meningioma.
Collapse
|
28
|
Cuccia F, Fiore MR, Barcellini A, Iannalfi A, Vischioni B, Ronchi S, Bonora M, Riva G, Vai A, Facoetti A, Preda L, Valvo F, Vitolo V. Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue Sarcomas. Anticancer Res 2020; 40:2853-2859. [PMID: 32366434 DOI: 10.21873/anticanres.14260] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2020] [Revised: 03/25/2020] [Accepted: 03/28/2020] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM Definitive radiotherapy for bone and soft tissues sarcomas benefits patients deemed unfit for surgery; poor outcomes have been reported with conventional photons, while interesting preliminary results have been described with particle in single-Institution experiences. The aim of the study was to retrospectively evaluate preliminary results of carbon ion radiotherapy (CIRT) in patients with axial bone and soft tissue sarcomas (BSTS) treated with curative intent at the National Center for Oncological Hadrontherapy (CNAO). PATIENTS AND METHODS From January 2013 to September 2018, 54 patients with axial BSTS were treated with CIRT at CNAO. Their median age was 50 years (range=19-79 years), males/females=1.4:1. Tumor site was the pelvis in 50% of cases (n=27), thoracic region in 24% (n=13), cervical spine in 15% (n=8) and lumbar in 11% (n=6). A total of 76% (n=41) of patients had primary disease, while 24% (n=13) had recurrent disease. Before CIRT, surgery was performed in 47% of cases, including positive margins (R1) in 8 patients, and macroscopic residual disease (R2) in 17. Histological subtypes were mainly represented by chondrosarcomas in 39% (n=21) of patients and osteosarcomas in 24% (n=13). Pre-treatment chemotherapy was administered in 40% of cases (n=22); no patient received previous radiotherapy. All treatments were performed with active scanning CIRT for a median total dose of 73.6 Gy (range=70.4-76.8 Gy), in 16 fractions (4 fractions per week). RESULTS Median follow-up was 24 months (range=4-61 months). Four patients were lost to follow-up. Acute toxicities were mild, no >G2 event was reported and no treatment interruption was required. For late toxicity, only G3 neuropathy was detected in 4% of cases (n=2). With a median time to local progression of 13 months (3-35), 15 local failures were observed, resulting in 2- and 3-year local control rates of 67.4% for both. Distant progression occurred in 12 patients, with 1-year progression-free survival (PFS) rate of 97.5%; 2- and 3-year rates were 92.2%. Fifteen patients died resulting in 1- 2- and 3-years overall survival (OS) rates of 87.1%, 75.4% and 64%, respectively. At log-rank test, gross total volume (GTV) >1,000 ml was found to be predictive of local failure (p=0.04), pre-treatment chemotherapy was found to be significantly related to PFS and OS (p=0.02 and p=0.016); also, recurrent disease and distant progression were significantly related to OS (p=0.019 and p=0.0013). Cox proportional-hazards model confirmed that GTV >1,000 ml was related to worse local control (p=0.0010). CONCLUSION CIRT for axial BSTS resulted in mild toxicity, showing promising results in terms of clinical outcomes. A longer follow-up is warranted.
Collapse
|
29
|
Vitolo V, Barcellini A, Mirandola A, Facoetti A, Iannalfi A, Vischioni B, Fiore MR, Brugnatelli S, Secondino S, Ronchi S, Bonora M, Preda L, Valvo F. Is Proton Beam Radiotherapy Worthwhile in the Management of Angiosarcoma of the Scalp? Anticancer Res 2020; 40:1645-1649. [PMID: 32132069 DOI: 10.21873/anticanres.14114] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2020] [Revised: 02/06/2020] [Accepted: 02/13/2020] [Indexed: 11/10/2022]
Abstract
In inoperable patients, the management of angiosarcoma of the scalp is challenging. Due to intrinsic, dosimetric and radiobiological properties, proton beam radiotherapy may be an effective and safe option to offer to these difficult-to-cure patients. Here, we report a case of angiosarcoma of the scalp treated successfully with proton beam radiotherapy. Angiosarcoma is a rare malignancy concerning around 2% of soft-tissue sarcomas and 5% of cutaneous soft-tissue sarcomas. Cutaneous angiosarcomas can occur in any part of the body, but the head and neck region is a common primary site and the scalp is a frequent site in elderly patients.
Collapse
|
30
|
Zoia C, Lombardi F, Fiore MR, Montalbetti A, Iannalfi A, Sansone M, Bongetta D, Valvo F, Del Maestro M, Luzzi S, Galzio RJ. Sacral solitary fibrous tumour: surgery and hadrontherapy, a combined treatment strategy. Rep Pract Oncol Radiother 2020; 25:241-244. [PMID: 32025222 DOI: 10.1016/j.rpor.2020.01.008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2019] [Revised: 10/24/2019] [Accepted: 01/24/2020] [Indexed: 11/17/2022] Open
|
31
|
Zoia C, Lombardi F, Custodi VM, Lovati E, Lucotti P, Iannalfi A, D'ippolito E, Valvo F, Bongetta D. Evaluation of the early endocrinological sequelae after hadron therapy on anterior skull base lesions in the adult population. MINERVA ENDOCRINOL 2019; 45:162-164. [PMID: 31738035 DOI: 10.23736/s0391-1977.19.03071-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
32
|
Viselner G, Farina L, Lucev F, Turpini E, Lungarotti L, Bacila A, Iannalfi A, D'Ippolito E, Vischioni B, Ronchi S, Marchioni E, Valvo F, Bastianello S, Preda L. Brain MR findings in patients treated with particle therapy for skull base tumors. Insights Imaging 2019; 10:94. [PMID: 31549243 PMCID: PMC6757093 DOI: 10.1186/s13244-019-0784-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2019] [Accepted: 08/19/2019] [Indexed: 12/27/2022] Open
Abstract
Nowadays, hadrontherapy is increasingly used for the treatment of various tumors, in particular of those resistant to conventional radiotherapy. Proton and carbon ions are characterized by physical and biological features that allow a high radiation dose to tumors, minimizing irradiation to adjacent normal tissues. For this reason, radioresistant tumors and tumors located near highly radiosensitive critical organs, such as skull base tumors, represent the best target for this kind of therapy. However, also hadrontherapy can be associated with radiation adverse effects, generally referred as acute, early-delayed and late-delayed. Among late-delayed effects, the most severe form of injury is radiation necrosis. There are various underlying mechanisms involved in the development of radiation necrosis, as well as different clinical presentations requiring specific treatments. In most cases, radiation necrosis presents as a single focal lesion, but it can be multifocal and involve a single or multiple lobes simulating brain metastasis, or it can also involve both cerebral hemispheres. In every case, radiation necrosis results always related to the extension of radiation delivery field. Multiple MRI techniques, including diffusion, perfusion imaging, and spectroscopy, are important tools for the radiologist to formulate the correct diagnosis. The aim of this paper is to illustrate the possible different radiologic patterns of radiation necrosis that can be observed in different MRI techniques in patients treated with hadrontherapy for tumors involving the skull base. The images of exemplary cases of radiation necrosis are also presented.
Collapse
|
33
|
Facoetti A, Aprile C, Cavagnini M, Ciocca M, Iannalfi A, Lodola L, Marenco M, Nano R, Pasi F, Persico M, Valvo F, Orecchia R. EP-2159 Influence of L-Dopa pretreatment on cellular features in T98G cells. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32579-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
34
|
Vischioni B, Dhanireddy B, Bonora M, Ronchi S, Vitolo V, Fiore M, D’Ippolito E, Petrucci R, Severo C, Ciurlia E, Hasegawa A, Iannalfi A, Valvo F, Orecchia R. PO-0728 reirradiation of salivary gland tumors with carbon ion radiotherapy (CIRT) at CNAO. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31148-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
35
|
D’Ippolito E, Iannalfi A, Bonora M, Vischioni B, Fiore M, Ronchi S, Vitolo V, Barcellini A, Petrucci R, Mirandola A, Maestri D, Magro G, Facoetti A, Viselner G, Ciocca M, Preda L, Valvo F, Orecchia R. PO-0741 Active spot-scanning proton therapy for intracranial meningiomas: CNAO experience. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31161-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
36
|
Barcellini A, Vitolo V, Fiore M, Iannalfi A, Vischioni B, Fossati P, Ronchi S, Bonora M, D'Ippolito E, Petrucci R, Facoetti A, Mirandola A, Vai A, Molinelli S, Mastella E, Russo S, Viselner G, Preda L, Ciocca M, Valvo F, Orecchia R. EP-1496 Feasibility of carbon ion radiotherapy for the melanoma of the lower genital tract. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31916-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
37
|
Buizza G, Paganelli C, Fontana G, Franconeri A, Raciti M, Pella A, Anemoni L, Iannalfi A, Preda L, Valvo F, Baroni G. EP-2051 A comparative analysis of MR signal normalization methods during proton therapy treatment. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32471-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
38
|
D’Ippolito E, Iannalfi A, Vischioni B, Vitolo V, Fiore M, Ronchi S, Bonora M, Barcellini A, Petrucci R, Mirandola A, Vai A, Mastella E, Viselner G, Ciocca M, Preda L, Valvo F, Orecchia R. EP-1147 Local control rate in patients with skull-base chondrosarcoma treated with particle therapy. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31567-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
39
|
Ronchi S, Vischioni B, Vitolo V, Bonora M, Hasegawa A, Fiore M, Iannalfi A, D’Ippolito E, Petrucci R, Barcellini A, Molinelli S, Maestri D, Viselner G, Facoetti A, Ciocca M, Preda L, Valvo F, Orecchia R. EP-1188 Carbon ion radiotherapy for recurrent pleomorphic adenoma at CNAO: preliminary results. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31608-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
40
|
Iannalfi A, D’Ippolito E, Vitolo V, Vischioni B, Fiore M, Bonora M, Ronchi S, Barcellini A, Petrucci R, Molinelli S, Mirandola A, Russo S, Facoetti A, Vai A, Mastella E, Viselner G, Magro G, Ciocca M, Preda L, Valvo F, Orecchia R. PO-0716 Skull-base chordoma treated with proton and carbon ion radiotherapy : CNAO clinical experience. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)31136-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
41
|
Vitolo V, Barcellini A, Fossati P, Fiore MR, Vischioni B, Iannalfi A, Facoetti A, Bonora M, Ronchi S, D'Ippolito E, Petrucci R, Viselner G, Preda L, Ciocca M, Valvo F, Orecchia R. Carbon Ion Radiotherapy in the Management of Unusual Liposarcomas: A Case Report. In Vivo 2019; 33:529-533. [PMID: 30804137 PMCID: PMC6506314 DOI: 10.21873/invivo.11506] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2018] [Revised: 12/07/2018] [Accepted: 12/11/2018] [Indexed: 01/15/2023]
Abstract
BACKGROUND Liposarcomas are the most common soft-tissue sarcomas in adulthood. Orbital and spermatic cord liposarcomas are uncommon and there is no consensus on their management. The treatment of choice is wide excision, which may be destructive and lead to unacceptable morbidity. When surgery is declined by patients and in recurrent disease, management can be challenging. We report two cases of liposarcoma treated with carbon ion radiotherapy at the National Center for Oncological Hadrontherapy (Fondazione CNAO) in Italy. CASE REPORT A woman with orbital liposarcoma and a man with spermatic cord liposarcoma were referred to our Center and accepted for carbon ion radiotherapy. The treatment was well tolerated and late toxicities were mild. Good local control was achieved in patients. CONCLUSION In our experience, carbon ion radiotherapy is an effective and safe option, especially in cases of tumor at high risk for local relapse, in patients with multiple local recurrences, and in patients who refuse destructive surgery.
Collapse
|
42
|
Barcellini A, Vitolo V, Facoetti A, Fossati P, Preda L, Fiore MR, Vischioni B, Iannalfi A, Bonora M, Ronchi S, D'Ippolito E, Petrucci R, Viselner G, Ciocca M, Valvo F, Orecchia R. Feasibility of Carbon Ion Radiotherapy in the Treatment of Gynecological Melanoma. In Vivo 2019; 33:473-476. [PMID: 30804128 PMCID: PMC6506293 DOI: 10.21873/invivo.11497] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2018] [Revised: 12/28/2018] [Accepted: 01/07/2019] [Indexed: 12/16/2022]
Abstract
BACKGROUND Malignant melanoma of the lower genital tract is a rare disease known to have a poor prognosis. Because of the high rate of distant metastasis and unsatisfactory survival benefit, a more conservative treatment approach, instead of extensive surgery, may be warranted. Gynecological melanoma is a radioresistant tumor, an ideal disease to test the biological efficacy of carbon ion radiotherapy (CIRT). AIM To report our preliminary experience with CIRT in the treatment of gynecological melanoma at the National Center of Oncological Hadrontherapy (CNAO). PATIENTS AND METHODS Between January 2016 and February 2017, four patients were admitted for CIRT at CNAO. A case of cervical melanoma was treated with palliative aim because of large volume macroscopic disease, while three cases of vaginal melanoma were irradiated with a total dose of 68.8 Gy (relative biological effectiveness) in 16 fractions delivered over 4 weeks (4 days a week). RESULTS The age of women ranged between 49 and 72 (median=60.5 years) years. Treatment was well tolerated in all patients and all women completed the scheduled treatment course. During CIRT, toxicity was mild. For patients with vaginal disease, local control was 10.23 and 12.6 months, while that for cervical malignant melanoma was 7.3 months. All patients experienced systemic progression, with median distant metastasis-free survival of 11.7 months. The median overall survival for the whole patient group was 11.41 months. CONCLUSION In our first experiences, CIRT appears to be a safe non-invasive option for malignant melanoma of the lower genital tract, but more data and longer follow-up are necessary in order to evaluate the effectiveness and late effects.
Collapse
|
43
|
Vitolo V, Fiore MR, Barcellini A, Vischioni B, Iannalfi A, Facoetti A, Fossati P, Bonora M, Ronchi S, D'Ippolito E, Petrucci R, Viselner G, Ciocca M, Preda L, Valvo F, Orecchia R. Carbon Ion Radiotherapy in the Management of the Tumors of the Peripheral Nervous System. Anticancer Res 2019; 39:909-913. [PMID: 30711975 DOI: 10.21873/anticanres.13193] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2018] [Revised: 12/13/2018] [Accepted: 12/17/2018] [Indexed: 11/10/2022]
Abstract
BACKGROUND/AIM Malignant peripheral nerve sheaths tumors (MPNST) are rare, highly aggressive and radioresistant tumors of soft tissue. Carbon ion radiotherapy (CIRT) seems to be an attractive treatment option when surgery is not possible or refused by the patient. The aim of this study was to report our preliminary results (outcomes and toxicity) of CIRT in the treatment of MPNSTs. PATIENTS AND METHODS Our study retrospectively analyzed 13 patients (median age=54 years; range=23-72 years) with MPNST treated with CIRT for a median total dose of 73.6 Gy (relative biological effectiveness) (range=70.4-76.8 Gy) between 2013 and 2016. RESULTS Six local progressions were recorded, with a median local progression-free survival of 23.2 months (range=2.2-45.4 months). Acute toxicities were mild. Late toxicity of grade 2 or more was noted in two patients. CONCLUSION CIRT yielded good local control with a low rate of acute and late toxicities.
Collapse
|
44
|
Garibaldi C, Ferrari M, Colandrea M, Cascio A, Ciocca M, Iannalfi A, D’Ippolito E, Pesente S, Grana C, Jereczek-Fossa B, Cremonesi M. 244. Target volume definition with MRI and 68 Ga-DOTATOC-PET/CT for patients with meningiomas. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.255] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
|
45
|
Picca A, Berzero G, Diamanti L, Bini P, Bacila A, Farina L, Bernini S, D’Ippolito E, Preda L, Iannalfi A. P05.84 Clinical and radiological patterns of brain radiation necrosis after ion beam radiotherapy for head and neck tumors. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
46
|
Iannalfi A, D’Ippolito E, Vitolo V, Vischioni B, Fiore M, Bonora M, Ronchi S, Caivano D, Barcellini A, Mirandola A, Molinelli S, Russo S, Facoetti A, Vai A, Mastella E, Viselner G, Raciti M, Fanizza M, Magro G, Maestri D, Ciocca M, Preda L, Valvo F, Orecchia R. P05.39 Skull-base chordoma treated with proton and carbon ion radiotherapy: C.N.A.O. clinical experience. Neuro Oncol 2018. [DOI: 10.1093/neuonc/noy139.365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
47
|
Buizza G, Paganelli C, Fontana G, Franconeri A, Raciti MV, Viselner G, Anemoni L, Iannalfi A, Preda L, Baroni G. [OA044] Quantitative DW-MRI for treatment evaluation in particle therapy: ROLE of ADC maps estimation. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.06.116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
|
48
|
Preda L, Stoppa D, Fiore MR, Fontana G, Camisa S, Sacchi R, Ghitti M, Viselner G, Fossati P, Valvo F, Vitolo V, Bonora M, Iannalfi A, Vischioni B, Vai A, Mastella E, Baroni G, Orecchia R. MRI evaluation of sacral chordoma treated with carbon ion radiotherapy alone. Radiother Oncol 2018; 128:203-208. [DOI: 10.1016/j.radonc.2017.11.029] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2017] [Revised: 11/20/2017] [Accepted: 11/30/2017] [Indexed: 11/16/2022]
|
49
|
Garibaldi C, Ferrari M, Colandrea M, Cascio A, Ciocca M, Iannalfi A, D'Ippolito E, Pesente S, Grana C, Cremonesi M. EP-2110: Target volume definition with MRI and 68Ga-DOTATOC-PET/CT for patients with meningiomas. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)32419-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
50
|
Caivano D, Vitolo V, Fiore M, Iannalfi A, Vischioni B, Bonora M, D'ippolito E, Ronchi S, Molinelli S, Ciocca M, Valvo F, Orecchia R. EP-1421: Carbon Ions In The Treatment Of Pancreatic Disease. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31730-4] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|